Evidence map›Paper›PMID 32979725›Full record

ArticleNuclear medicine and biology

A kit formulation for the preparation of [

Francis Man, Azalea A Khan, Amaia Carrascal-Miniño, Philip J Blower, Rafael T M de Rosales

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Nuclear medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. First-in-human dosimetry and biodistribution of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
  3. Article
  4. Tracking macrophages by direct and indirectEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. In Vivo PET Imaging ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  13. First-in-human infection imaging withFrontiers in nuclear medicine · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Evaluation of differentScientific reports · 2022
    Article
  18. Direct Cell Radiolabeling forChemical reviews · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Francis ManSchool of Biomedical Engineering & Imaging Sciences, King's College London, London SE1 7EH, UK. Electronic address: francis.man@kcl.ac.uk.
Azalea A KhanSchool of Biomedical Engineering & Imaging Sciences, King's College London, London SE1 7EH, UK.
Amaia Carrascal-MiniñoSchool of Biomedical Engineering & Imaging Sciences, King's College London, London SE1 7EH, UK.
Philip J BlowerSchool of Biomedical Engineering & Imaging Sciences, King's College London, London SE1 7EH, UK.
Rafael T M de RosalesSchool of Biomedical Engineering & Imaging Sciences, King's College London, London SE1 7EH, UK. Electronic address: rafael.torres@kcl.ac.uk.
King's College London · GB

Funding

Cancer Research UK A21153Cancer Research UK C48390/A21153Department of Health IS-BRC-1215-20006Medical Research CouncilWellcome Trust 203148Wellcome Trust 212885Wellcome Trust WT 203148/Z/16/Z
6 · The paper itself

Abstract

backgroundAdvances in immunology and cell-based therapies are creating a need to track individual cell types, such as immune cells (neutrophils, eosinophils, chimeric antigen receptor (CAR) T cells, etc.) and stem cells. As the fate of administered cells remains largely unknown, nuclear imaging could determine the migration and survival of cells in patients. [

methodsCommercial [

resultsAn optimised formulation of [

Indexed as

Cell TrackingIsotope LabelingLeukocytesPositron-Emission TomographyZirconiumHumansIndium RadioisotopesOrganometallic CompoundsOxyquinolineRadiochemistryRadioisotopesindium oxineIndium RadioisotopesOrganometallic CompoundsOxyquinolineRadioisotopesZirconiumZirconium-89CAR-TCell therapyCell trackingNanomedicinePETZirconium-89

Identifiers

PMID32979725
PMCPMC7116765
OpenAlexW3087801316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.